Ajanta Pharma denies Burger King stake acquisition rumours
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Midcap 150 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ajanta Pharma has officially denied media reports linking it to a potential stake acquisition in Restaurant Brands Asia, the operator of Burger King in India. Reuters and other publications had mentioned Ajanta in connection with a stake purchase by Everstone. Ajanta clarified that neither the company nor its management is party to or involved in the transaction, and has not entered into, discussed, negotiated, or considered any such proposal. The company called the reference in the news article incorrect and denied circulating speculation on social media.
Removes speculative acquisition upside. Stock may remain volatile from social media chatter despite official denial of rumours.